We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Former CDER division director joins Lightlake Therapeutics

This article was originally published in SRA

26 Apr 2011

News

Zoë Dann

Executive Summary

The UK-based early stage biopharmaceutical company Lightlake Therapeutics has appointed Cynthia McCormick as a senior clinical and regulatory advisor. Dr McCormick is the former director of the division of anaesthetic, critical care and addiction drug products at the Office of Drug Evaluation, part of the Center for Drug Evaluation and Research at the US Food and Drug Administration.